Modulating effect of Biophytum sensitivum extract on rats with acetic acid-induced ulcerative colitis

Pharmaceutical Biology

Volumn 52, Issue 12, 2014, Pages 1570-1580

  Sakthivel, K M ^a   Guruvayoorappan, C ^a  

^a KARUNYA UNIVERSITY   (India)

Author keywords

Acetic acid; Inflammatory mediators; Pro inflammatory cytokines

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOPHYTUM SENSITIVUM EXTRACT; CYCLOOXYGENASE 2; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; NITRIC OXIDE; PLANT EXTRACT; SALAZOSULFAPYRIDINE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACETIC ACID; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOPHYTUM SENSITIVUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; INTESTINE MUCOSA PERMEABILITY; LIPID PEROXIDATION; MALE; NONHUMAN; OXALIDACEAE; OXIDATIVE STRESS; RAT; SPLEEN WEIGHT; ULCERATIVE COLITIS; ANIMAL; CHEMISTRY; COLITIS, ULCERATIVE; COMPARATIVE STUDY; DISEASE MODEL; METABOLISM; PLANT STRUCTURES; WISTAR RAT;

ACETIC ACID; ANIMALS; COLITIS, ULCERATIVE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; L-LACTATE DEHYDROGENASE; MALE; OXALIDACEAE; PEROXIDASE; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; RATS; RATS, WISTAR; SULFASALAZINE;

EID: 84908700779     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.908396     Document Type: Article

References (35)

1. References Alzoghaibi MA, Al-Mofleh IA, Al-Jebreen AM. (2007). Lipid peroxides in patients with inflammatory bowel disease. Saudi J Gastroenterol 13:187-90.
2. Amini-Shirazi N, Hoseini A, Ranjbar A, et al. (2009). Inhibition of tumor necrosis factor and nitrosative/oxidative stresses by Ziziphoraclinopoides (Kahlioti); a molecular mechanism of protection against dextran sodium sulfate-induced colitis in mice. Toxicol Mech Methods 19:183-9.
3. Arafa HM, Hemeida RA, El-Bahrawy Al, Hamada FM. (2009). Prophylactic role of curcumin in dextran sulfate sodium (DSS)- induced ulcerative colitis murine model. Food Chem Toxicol 47: 1311-17.
4. Ardizzone S, Porro GB. (2005). Biologic therapy for inflammatory bowel disease. Drugs 65:2253-86.
5. Bauerle PA, Henkel T. (1994). Function and activation of NF-kB in the immune system. Ann Rev Immunol 2:141-79.
6. Berkhout M, Friederich P, Van Krieken JH, et al. (2006). Low detoxification capacity in the ileal pouch mucosa of patients with ulcerative colitis. Inflamm Bowel Dis 12:112-16.
7. Cho EJ, Shin JS, Noh YS, et al. (2011). Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis. J Ethnopharmacol 136:428-35.
8. Coskun M, Olsen J, Seidelin JB, Nielsen OH. (2011). MAP kinases in inflammatory bowel disease. Clin Chim Acta 412:513-20.
9. Eaden JA, Mayberry JF. (2002). Guidelines for screening surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51:10-12.
10. Erickson RA, Chang K, Lifrak E, et al. (1992). 16, 16-Dimethyl prostaglandin E2 reduces bile acid-mediated intestinal vascular injury in rats. Gastroenterology 102:1295-305.
11. Goldstein JL, Silverstein FE, Agrawal NM, et al. (2000). Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 95:1681-90.
12. Green LC, Wagner DA, Glogowski J, et al. (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126: 131-8.
13. Guruvayoorappan C, Afira AH, Kuttan G. (2006). Antioxidant potential of Biophytum sensitivum extract in vitro and in vivo. J Basic Clin Physiol Pharmacol 17:255-67.
14. Guruvayoorappan C, Kuttan G. (2007a). Anti-angiogenic effect of Biophytum sensitivum is exerted through its cytokine modulation activity and inhibitory activity against VEGF mRNA expression and endothelial cell migration and capillary tube formation. J Exp Ther Oncol 6:241-50.
15. Guruvayoorappan C, Kuttan G. (2007b). Immunomodulatory and antitumour activity of Biophytum sensitivum extract. Asian Pac J Cancer Prev 8:27-32.
16. Guruvayoorappan C, Kuttan G. (2008). Methanol extract of Biophytum sensitivum alters the cytokine profiles and inhibits iNOS and COX-2 expression in LPS/Con A stimulated macrophages. Drug Chem Toxicol 31:175-88.
17. Hagar HH, El-Medany A, El-Eter E, Arafa M. (2007). Ameliorative effect of pyrrolidine dithiocarbamate on acetic acid-induced colitis in rats. Eur J Pharmacol 554:69-77.
18. Itzkowitz SH. (2006). Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am 35:553-71.
19. Jagtap AG, Shirke SS, Phadke AS. (2004). Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. J Ethnopharmacol 90:195-204.
20. Jirovetz L, Buchbauer G,Wobus A, et al. (2004). Medicinally used plants from India: Analysis of the essential oil of air-dried Biophytum sensitivum (L.) DC. Sci Pharm 72:87-96.
21. Kakkar K, Das P, Viswanathan P. (1984). A modified method for assay of superoxide dismutase. Ind J Biochem Biophys 21:131-2.
22. Karin M, Greten FR. (2005). NF-kB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-59.
23. Kruidenier L, Verspaget HW. (2002). Oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous? Aliment Pharmacol Ther 16:1997-2015
24. Kundu JK, Surh YJ. (2004). Molecular basis of chemoprevention by resveratrol: NF-kB and AP-1 as potential targets. Mutat Res 555: 65-80.
25. Kuo MY, Ou HC, Lee WJ, et al. (2011). Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C alpha/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor gamma/nuclear factor-kappaB (PKC-alpha/ERK/PPAR-gamma/NF-kappaB) signaling pathway in endothelial cells. J Agric Food Chem 59:5100-8.
26. Millar AD, Rampton DS, Chander CL, et al. (1996). Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39:407-15.
27. Moron MS, Depierre JW, Mannervik B. (1979). Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67-78.
28. Ohkawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-8.
29. Oktyabrsky ON, Smirnova GV. (2007). Redox regulation of cellular functions. Biochem (Mosc) 72:132-45.
30. Pratheeshkumar P, Tharakan, JR, Girija Kuttan. (2012). Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells. Integr Cancer Ther 11:48-60.
31. Sakthivel KM, Guruvayoorappan C. (2012). Biophytum sensitivum: Ancient medicine, modern targets. J Adv Pharm Technol Res 3:83-91.
32. Van der Veen BS, de Winther MP, Heeringa P. (2009). Myeloperoxidase: Molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11:2899-937.
33. Viera N, Silvia C, Viktor B. (2000). Effect of N-acetylcysteine on colitis induced by acetic acid in rats. Gen Pharmacol 35:77-81.
34. Wang YH, Ge B, Yang XL, et al. (2011). Proanthocyanidins from grape seeds modulates the nuclear factor-kappa B signal transduction pathways in rats with TNBS-induced recurrent ulcerative colitis. Int Immunopharmacol 11:1620-7.
35. Xu CT, Meng SY, Pan BR. (2004). Drug therapy for ulcerative colitis. World J Gastroenterol 10:2311-17.